litlas
Log inCreate account

Stefani Spranger

Active 2009–2026

65
Papers
18,584
Citations
48
h-index
62
i10-index

Citations

Citations per year for Stefani Spranger1995: 1 citations2003: 2 citations2010: 5 citations2011: 5 citations2012: 5 citations2013: 17 citations2014: 57 citations2015: 154 citations2016: 293 citations2017: 411 citations2018: 498 citations2019: 1,168 citations2020: 1,560 citations2021: 1,421 citations2022: 1,161 citations2023: 925 citations2024: 1,201 citations2025: 736 citations2026: 15 citations1996–2002: no citations, so these years are not shown2004–2009: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,226 citing papers, 28.6% of this breakdownChina: 2,219 citing papers, 19.7% of this breakdownGermany: 504 citing papers, 4.5% of this breakdownUnited Kingdom: 482 citing papers, 4.3% of this breakdownFrance: 439 citing papers, 3.9% of this breakdownItaly: 436 citing papers, 3.9% of this breakdownJapan: 313 citing papers, 2.8% of this breakdownSpain: 284 citing papers, 2.5% of this breakdownNetherlands: 281 citing papers, 2.5% of this breakdownAustralia: 276 citing papers, 2.4% of this breakdownSwitzerland: 271 citing papers, 2.4% of this breakdownCanada: 252 citing papers, 2.2% of this breakdown
0%28.6%Other 20.3%

Institutions

Fields

  • Medicine47.4%
  • Immunology and Microbiology28.3%
  • Biochemistry, Genetics and Molecular Biology18.3%
  • Neuroscience2.6%
  • Engineering2.2%
  • Materials Science0.3%
  • Other0.9%

Topics

  • Cancer Immunotherapy and Biomarkers15.1%
  • Immunotherapy and Immune Responses10%
  • Immune Cell Function and Interaction6.1%
  • CAR-T cell therapy research5.3%
  • Immune cells in cancer4.8%
  • interferon and immune responses3.8%
  • Other54.9%

Coauthors

All papers

Open in search
  1. STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors

    Authors: Seng‐Ryong Woo, Mercedes B. Fuertes, Leticia Corrales, Stefani Spranger, Michael J. Furdyna, Michael Y.K. Leung, Ryan Duggan, Ying Wang, Glen N. Barber, Katherine A. Fitzgerald, Maria-Luisa Alegre, Thomas F. Gajewski - Immunity 2014 cited by 1,834

  2. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

    Authors: Stefani Spranger, Riyue Bao, Thomas F. Gajewski - Nature 2015 cited by 2,840

  3. Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy

    Authors: Stefani Spranger, Daisy Dai, Brendan Horton, Thomas F. Gajewski - Cancer Cell 2017 cited by 1,410

  4. Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Authors: Weiyi Peng, Jie Qing Chen, Chengwen Liu, Shruti Malu, Caitlin Creasy, Michael T. Tetzlaff, Chunyu Xu, Jodi A. McKenzie, Chunlei Zhang, Xiaoxuan Liang, Leila J. Williams, Wanleng Deng, Guo Chen, Rina M. Mbofung, Alexander J. Lazar, Carlos A. Torres‐Cabala, Zachary A. Cooper, Pei-Ling Chen, Trang N. Tieu, Stefani Spranger, Xiaoxing Yu, Chantale Bernatchez, Marie‐Andrée Forget, Cara Haymaker, Rodabe N. Amaria, Jennifer L. McQuade, Isabella C. Glitza, Tina Cascone, Haiyan S. Li, Lawrence N. Kwong, Timothy P. Heffernan, Jianhua Hu, Roland L. Bassett, Marcus Bosenberg, Scott E. Woodman, Willem W. Overwijk, Gregory Lizée, Jason Roszik, Thomas F. Gajewski, Jennifer A. Wargo, Jeffrey E. Gershenwald, Laszlo Radvanyi, Michael A. Davies, Patrick Hwu - Cancer Discovery 2015 cited by 1,531

  5. Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

    Authors: Ellen Duong, Tim Fessenden, Emi A. Lutz, Teresa Dinter, Leon Yim, Sarah E. Blatt, Arjun Bhutkar, K. Dane Wittrup, Stefani Spranger - Immunity 2021 cited by 356

  6. Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells

    Authors: Stefani Spranger, Robbert M. Spaapen, Yuanyuan Zha, Jason B. Williams, Yuru Meng, Thanh T. Ha, Thomas F. Gajewski - Science Translational Medicine 2013 cited by 1,674

  7. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

    Authors: Jason J. Luke, Riyue Bao, Randy F. Sweis, Stefani Spranger, Thomas F. Gajewski - Clinical Cancer Research 2019 cited by 692

  8. Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer

    Authors: Maria Zagorulya, Leon Yim, Duncan M. Morgan, Austin Edwards, Elen Torres-Mejia, Noor Momin, Chloe V. McCreery, Izabella Zamora, Brendan Horton, James G. Fox, K. Dane Wittrup, J. Christopher Love, Stefani Spranger - Immunity 2023 cited by 148

  9. Impact of oncogenic pathways on evasion of antitumour immune responses

    Authors: Stefani Spranger, Thomas F. Gajewski - Nature reviews. Cancer 2018 cited by 658

  10. Innate immune signaling and regulation in cancer immunotherapy

    Authors: Leticia Corrales, Vyara Matson, Blake Flood, Stefani Spranger, Thomas F. Gajewski - Cell Research 2016 cited by 421

  11. Lack of CD8 + T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer

    Authors: Brendan Horton, Duncan M. Morgan, Noor Momin, Maria Zagorulya, Elen Torres-Mejia, Vidit Bhandarkar, K. Dane Wittrup, J. Christopher Love, Stefani Spranger - Science Immunology 2021 cited by 129

  12. Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy

    Authors: Noor Momin, Naveen K. Mehta, Nitasha R. Bennett, Leyuan Ma, Joseph R. Palmeri, Magnolia M. Chinn, Emi A. Lutz, Byong H. Kang, Darrell J. Irvine, Stefani Spranger, K. Dane Wittrup - Science Translational Medicine 2019 cited by 208

  13. Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

    Authors: Stefani Spranger, Holly K. Koblish, Brendan Horton, Peggy Scherle, Robert Newton, Thomas F. Gajewski - Journal for ImmunoTherapy of Cancer 2014 cited by 545

  14. Deciphering the immunopeptidome in vivo reveals new tumour antigens

    Authors: Alex M. Jaeger, Lauren Stopfer, Ryuhjin Ahn, Emma A. Sanders, Demi Sandel, William A. Freed-Pastor, William M. Rideout, Santiago Naranjo, Tim Fessenden, Kim B. Nguyen, Peter Winter, Ryan Kohn, Peter M.K. Westcott, Jason M. Schenkel, Sean-Luc Shanahan, Alex K. Shalek, Stefani Spranger, Forest M. White, Tyler Jacks - Nature 2022 cited by 104

  15. Cancer immune evasion, immunoediting and intratumour heterogeneity

    Authors: Malte Roerden, Stefani Spranger - Nature reviews. Immunology 2025 cited by 185

  16. Direct and Indirect Regulators of Epithelial–Mesenchymal Transition–Mediated Immunosuppression in Breast Carcinomas

    Authors: Anushka Dongre, Mohammad Rashidian, Elinor Ng Eaton, Ferenc Reinhardt, Prathapan Thiru, Maria Zagorulya, Sunita Nepal, Tuba Banaz, Anna Martner, Stefani Spranger, Robert A. Weinberg - Cancer Discovery 2020 cited by 142

  17. Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy

    Authors: Lijie Zhai, Stefani Spranger, David C. Binder, Galina Gritsina, Kristen L. Lauing, Francis J. Giles, Derek A. Wainwright - Clinical Cancer Research 2015 cited by 324

  18. WNT Signaling in Cancer Immunosurveillance

    Authors: Lorenzo Galluzzi, Stefani Spranger, Elaine Fuchs, Alejandro López‐Soto - Trends in Cell Biology 2018 cited by 243

  19. Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma

    Authors: Stefani Spranger, Jason J. Luke, Riyue Bao, Yuanyuan Zha, Kyle M. Hernandez, Li Yan, Alexander P. Gajewski, Jorge Andrade, Thomas F. Gajewski - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 413

  20. Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation

    Authors: Sachin Bhagchandani, Farrukh Vohidov, Lauren E. Milling, Yuzhou Evelyn Tong, Christopher M. Brown, Michelle L. Ramseier, Bin Liu, Timothy Fessenden, Hung V.‐T. Nguyen, Gavin R. Kiel, Lori Won, Róbert Langer, Stefani Spranger, Alex K. Shalek, Darrell J. Irvine, Jeremiah A. Johnson - Science Advances 2023 cited by 56

  21. Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

    Authors: Thomas F. Gajewski, Seng‐Ryong Woo, Yuanyuan Zha, Robbert M. Spaapen, Yan Zheng, Leticia Corrales, Stefani Spranger - Current Opinion in Immunology 2013 cited by 429

  22. A prime editor mouse to model a broad spectrum of somatic mutations in vivo

    Authors: Zackery A. Ely, Nicolas Mathey‐Andrews, Santiago Naranjo, Samuel I. Gould, Kim L. Mercer, Gregory A. Newby, Christina M. Cabana, William M. Rideout, Grissel Cervantes-Jaramillo, Jennifer Khirallah, Katie Holland, Peyton B. Randolph, William A. Freed-Pastor, Jessie R. Davis, Zachary Kulstad, Peter M.K. Westcott, Lin Lin, Andrew V. Anzalone, Brendan Horton, Nimisha B. Pattada, Sean-Luc Shanahan, Zhongfeng Ye, Stefani Spranger, Qiaobing Xu, Francisco J. Sánchez‐Rivera, David R. Liu, Tyler Jacks - Nature Biotechnology 2023 cited by 58

  23. Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies

    Authors: Brianna M. Lax, Joseph R. Palmeri, Emi A. Lutz, Allison Sheen, Jordan A. Stinson, Lauren Duhamel, Luciano Santollani, Alan Kennedy, Adrienne M. Rothschilds, Stefani Spranger, David M. Sansom, K. Dane Wittrup - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 53

  24. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment

    Authors: Stefani Spranger - International Immunology 2016 cited by 297